34719812|t|Moderate blood alcohol and brain neurovulnerability: Selective depletion of calcium-independent phospholipase A2, omega-3 docosahexaenoic acid, and its synaptamide derivative as a potential harbinger of deficits in anti-inflammatory reserve.
34719812|a|BACKGROUND: Repetitive, highly elevated blood alcohol (ethanol) concentrations (BACs) of 350 to 450 mg/dl over several days cause brain neurodegeneration and coincident neuroinflammation in adult rats localized in the hippocampus (HC), temporal cortex (especially the entorhinal cortex; ECX), and olfactory bulb (OB). The profuse neuroinflammation involves microgliosis, increased proinflammatory cytokines, and elevations of Ca+2 -dependent phospholipase A2 (cPLA2) and secretory PLA2 (sPLA2), which both mobilize proinflammatory omega-6 arachidonic acid (ARA). In contrast, Ca+2 -independent PLA2 (iPLA2) and anti-inflammatory omega-3 docosahexaenoic acid (DHA), a polyunsaturated fatty acid regulated primarily by iPLA2, are diminished. Furthermore, supplemented DHA exerts neuroprotection. Given uncertainties about the possible effects of lower circulating BACs that are common occurring during short- term binges, we examined how moderate BACs affected the above inflammatory events, and the impact of supplemented DHA. METHODS AND RESULTS: Young adult male rats sustaining upper-moderate BACs (~150 mg/dl) from once-daily alcohol intubations were sacrificed with appropriate controls after 1 week. The HC, ECX and OB were quantitatively examined using immunoblotting, neurodegeneration staining, and lipidomics assays. Whereas neurodegeneration, increases in cPLA2 IVA, sPLA2 IIA, and ARA, and microglial activation were not detected, the HC and ECX regions demonstrated significantly reduced iPLA2 levels. Levels of DHA and synaptamide, its anti-inflammatory N-docosahexaenoylethanolamide derivative, also were lower in HC, and DHA supplementation prevented the iPLA2 decrements in HC. Additionally, adult mice maintaining upper-moderate BACs from limited alcohol binges had reduced midbrain iPLA2 levels. CONCLUSIONS: The apparently selective depletion by moderate BACs of the metabolically linked anti-inflammatory triad of hippocampal iPLA2, DHA, and synaptamide, and of iPLA2 in the ECX, potentially indicates an unappreciated deficit in brain anti-inflammatory reserve that may be a harbinger of regional neurovulnerability.
34719812	15	22	alcohol	Chemical	MESH:D000438
34719812	96	112	phospholipase A2	Gene	29526
34719812	114	142	omega-3 docosahexaenoic acid	Chemical	-
34719812	152	163	synaptamide	Chemical	MESH:C000628804
34719812	220	232	inflammatory	Disease	MESH:D007249
34719812	288	295	alcohol	Chemical	MESH:D000438
34719812	297	304	ethanol	Chemical	MESH:D000431
34719812	378	395	neurodegeneration	Disease	MESH:D019636
34719812	411	428	neuroinflammation	Disease	MESH:D000090862
34719812	438	442	rats	Species	10116
34719812	529	532	ECX	Disease	
34719812	572	589	neuroinflammation	Disease	MESH:D000090862
34719812	599	611	microgliosis	Disease	
34719812	668	700	Ca+2 -dependent phospholipase A2	Gene	24653
34719812	702	707	cPLA2	Gene	24653
34719812	729	734	sPLA2	Gene	29692
34719812	773	797	omega-6 arachidonic acid	Chemical	-
34719812	799	802	ARA	Chemical	MESH:D016718
34719812	842	847	iPLA2	Gene	53357
34719812	858	870	inflammatory	Disease	MESH:D007249
34719812	871	899	omega-3 docosahexaenoic acid	Chemical	-
34719812	901	904	DHA	Chemical	MESH:D004281
34719812	909	935	polyunsaturated fatty acid	Chemical	MESH:D005231
34719812	959	964	iPLA2	Gene	360426
34719812	1008	1011	DHA	Chemical	MESH:D004281
34719812	1211	1223	inflammatory	Disease	MESH:D007249
34719812	1263	1266	DHA	Chemical	MESH:D004281
34719812	1306	1310	rats	Species	10116
34719812	1371	1378	alcohol	Chemical	MESH:D000438
34719812	1455	1458	ECX	Disease	
34719812	1517	1534	neurodegeneration	Disease	MESH:D019636
34719812	1576	1593	neurodegeneration	Disease	MESH:D019636
34719812	1634	1637	ARA	Chemical	MESH:D016718
34719812	1695	1698	ECX	Disease	
34719812	1742	1747	iPLA2	Gene	360426
34719812	1766	1769	DHA	Chemical	MESH:D004281
34719812	1774	1785	synaptamide	Chemical	MESH:C000628804
34719812	1796	1808	inflammatory	Disease	MESH:D007249
34719812	1809	1838	N-docosahexaenoylethanolamide	Chemical	MESH:C561061
34719812	1878	1881	DHA	Chemical	MESH:D004281
34719812	1912	1917	iPLA2	Gene	360426
34719812	1956	1960	mice	Species	10090
34719812	2006	2013	alcohol	Chemical	MESH:D000438
34719812	2042	2047	iPLA2	Gene	53357
34719812	2154	2166	inflammatory	Disease	MESH:D007249
34719812	2188	2193	iPLA2	Gene	360426
34719812	2195	2198	DHA	Chemical	MESH:D004281
34719812	2204	2215	synaptamide	Chemical	MESH:C000628804
34719812	2224	2229	iPLA2	Gene	360426
34719812	2237	2240	ECX	Disease	
34719812	2303	2315	inflammatory	Disease	MESH:D007249
34719812	Association	MESH:D000090862	24653
34719812	Negative_Correlation	MESH:D004281	MESH:D007249
34719812	Association	MESH:D007249	360426
34719812	Association	MESH:D000438	29526
34719812	Negative_Correlation	MESH:D004281	360426
34719812	Association	MESH:D007249	29526
34719812	Negative_Correlation	MESH:D000438	360426
34719812	Negative_Correlation	MESH:D000438	MESH:D004281
34719812	Association	MESH:D019636	360426
34719812	Positive_Correlation	MESH:D000431	MESH:D019636
34719812	Negative_Correlation	MESH:D000438	53357
34719812	Negative_Correlation	MESH:C561061	MESH:D007249
34719812	Positive_Correlation	MESH:D000438	MESH:D000090862
34719812	Positive_Correlation	MESH:D000438	MESH:D019636
34719812	Association	MESH:D000090862	29692
34719812	Positive_Correlation	MESH:D000431	MESH:D000090862
34719812	Negative_Correlation	MESH:C000628804	MESH:D007249

